CALL/ROCHE GS/200/0.1/19.12.25 Share Price

Warrant

DE000GG37F81

Real-time BOERSE MUENCHEN 12:36:45 18/07/2024 pm IST
8.45 EUR +3.30% Intraday chart for CALL/ROCHE GS/200/0.1/19.12.25
Current month+41.52%
1 month+47.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
18/24/18 8.45 +3.30%
17/24/17 8.18 +25.65%
16/24/16 6.51 +1.09%
15/24/15 6.44 +5.06%
12/24/12 6.13 +5.51%

Real-time BOERSE MUENCHEN

Last update July 18, 2024 at 12:36 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ROCHE HOLDING AG
Issuer Goldman Sachs
WKN GG37F8
ISINDE000GG37F81
Date issued 07/02/2024
Strike 200 CHF
Maturity 19/12/2025 (520 Days)
Parity 10 : 1
Emission price 3.69
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 8.45
Lowest since issue 2.78
Delta0.86x
Omega 2.946
Premium1.45x
Gearing3.43x
Moneyness 1.384
Difference Strike -76.25 CHF
Difference Strike %-38.13%
Spread 0.1
Spread %1.19%
Theoretical value 8.370
Implied Volatility 29.84 %
Total Loss Probability 25.15 %
Intrinsic value 7.944
Present value 0.4258
Break even 280.92 €
Theta-0.01x
Vega0.07x
Rho0.13x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
274 CHF
Average target price
274 CHF
Spread / Average Target
0.00%
Consensus